132 related articles for article (PubMed ID: 11427227)
1. Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study.
Price JF; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Atherosclerosis; 2001 Jul; 157(1):241-9. PubMed ID: 11427227
[TBL] [Abstract][Full Text] [Related]
2. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.
Bostom AG; Gagnon DR; Cupples LA; Wilson PW; Jenner JL; Ordovas JM; Schaefer EJ; Castelli WP
Circulation; 1994 Oct; 90(4):1688-95. PubMed ID: 7923652
[TBL] [Abstract][Full Text] [Related]
3. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.
Leng GC; Lee AJ; Fowkes FG; Whiteman M; Dunbar J; Housley E; Ruckley CV
Int J Epidemiol; 1996 Dec; 25(6):1172-81. PubMed ID: 9027521
[TBL] [Abstract][Full Text] [Related]
4. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.
Fowkes FG; Housley E; Cawood EH; Macintyre CC; Ruckley CV; Prescott RJ
Int J Epidemiol; 1991 Jun; 20(2):384-92. PubMed ID: 1917239
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Lee AJ; Lowe GD; Woodward M; Tunstall-Pedoe H
Br Heart J; 1993 Apr; 69(4):338-42. PubMed ID: 8489866
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study.
Leng GC; Lee AJ; Fowkes FG; Lowe GD; Housley E
Eur Heart J; 1995 Nov; 16(11):1542-8. PubMed ID: 16032787
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.
von Eckardstein A; Schulte H; Cullen P; Assmann G
J Am Coll Cardiol; 2001 Feb; 37(2):434-9. PubMed ID: 11216959
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of prospective studies.
Genser B; Dias KC; Siekmeier R; Stojakovic T; Grammer T; Maerz W
Clin Lab; 2011; 57(3-4):143-56. PubMed ID: 21500721
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik J; Rifai N; Buring JE; Ridker PM
JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.
Brand FN; Abbott RD; Kannel WB
Diabetes; 1989 Apr; 38(4):504-9. PubMed ID: 2925008
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of aspirin use and primary prevention of cardiovascular disease in women.
Manson JE; Stampfer MJ; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
JAMA; 1991 Jul 24-31; 266(4):521-7. PubMed ID: 2061978
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study).
Cantin B; Moorjani S; Dagenais GR; Lupien PJ
Am J Cardiol; 1995 Jun; 75(17):1224-8. PubMed ID: 7778544
[TBL] [Abstract][Full Text] [Related]
14. [High level of lipoprotein (a) as a predictor of poor long-term prognosis after coronary artery bypass surgery].
Ezhov MV; Safarova MC; Afanas'eva OI; Il'ina LN; Liakishev AA; Pokrovskiĭ SN
Kardiologiia; 2011; 51(1):18-22. PubMed ID: 21626797
[TBL] [Abstract][Full Text] [Related]
15. Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study.
Housley E; Leng GC; Donnan PT; Fowkes FG
J Epidemiol Community Health; 1993 Dec; 47(6):475-80. PubMed ID: 8120503
[TBL] [Abstract][Full Text] [Related]
16. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.
Lowe G; Rumley A; Norrie J; Ford I; Shepherd J; Cobbe S; Macfarlane P; Packard C
Thromb Haemost; 2000 Oct; 84(4):553-8. PubMed ID: 11057849
[TBL] [Abstract][Full Text] [Related]
17. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
[TBL] [Abstract][Full Text] [Related]
18. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
Price JF; Mowbray PI; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Eur Heart J; 1999 Mar; 20(5):344-53. PubMed ID: 10206381
[TBL] [Abstract][Full Text] [Related]
19. Lp(a) lipoprotein, vascular disease, and mortality in the elderly.
Ariyo AA; Thach C; Tracy R;
N Engl J Med; 2003 Nov; 349(22):2108-15. PubMed ID: 14645638
[TBL] [Abstract][Full Text] [Related]
20. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
Circulation; 1990 Jul; 82(1):27-36. PubMed ID: 2194696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
